ResMed (NYSE:RMD) just disclosed its Q2 earnings on Thursday, January 29, 2026 at 04:05 PM.

Here's a brief overview of the earnings report.

Earnings

ResMed beat estimated earnings by 4.0%, reporting an EPS of $2.81 versus an estimate of $2.71.

Revenue was up $140.81 million from the same period last year.

Previous Earnings Records

Last quarter the company beat on EPS by $0.05 which was followed by a 2.0% drop in the share price the next day.

Here's a look at ResMed's past performance:

To track all earnings releases for ResMed visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.